5-10 business days

Tasisulam is a anticancer agent and induces apoptosis via the intrinsic pathway, resulting in cytochrome c release and caspase-dependent cell death. Tasisulam inhibits mitotic progression and induces vascular normalization.

Product Name Tasisulam
CAS Number 519055-62-0
Related CAS
Molecular Formula C11H6BrCl2NO3S2
Molecular Weight 415.1
SMILES ClC1=CC(Cl)=C(C=C1)C(=O)NS(=O)(=O)C1=CC=C(Br)S1
Purity (HPLC) >= 95%
Physical Appearance White solid
Solubility DMSO, DMF
Shipping Conditions Room Temperature
Storage Conditions Refrigerated
Shelf Life 12 months after the date of delivery
Regulatory Statement For Research Use Only


Li, H., Dong, J., Cai, M., Xu, Z., Cheng, X.-D.,Qin, J.-J., Protein degradation technology: a strategic paradigm shift in drug discovery. Journal of Hematology & Oncology 2021, 14, 138.Xu, Y., Nijhuis, A.,Keun, H. C., RNA-binding motif protein 39 (RBM39): An emerging cancer target. British Journal of Pharmacology n/a.



Datasheet         COA           MSDS



If you know of a paper that uses this product from Tenova Pharma, please let us know.